EGIS Pharmaceuticals Public Limited Company (Hungary) with the headquarters in Budapest, is one of the pharmaceutical companies operating generally in Central and Eastern Europe.
The main field of activity of the company is the research, development and sale of pharmaceutical medicines and active pharmaceutical substances for treatment of cardiovascular diseases, diseases of the central nervous system and also frustration of the respiratory and digestive systems. The company distributes the products in many countries of the world through the business partners and powerful network of affiliated enterprises.
History
1995: Servier - the core shareholder and the partner of EGIS
In December, 1995 the French company "Servye" became the core shareholder and the strategic partner of EGIS ltd.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |